Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-040395
Filing Date
2023-04-03
Accepted
2023-03-31 20:14:56
Documents
3
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2311190d1_6k.htm 6-K 10563
2 EXHIBIT 99.1 tm2311190d1_ex99-1.htm EX-99.1 54599
3 GRAPHIC logo.jpg GRAPHIC 3169
  Complete submission text file 0001104659-23-040395.txt   70647
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41359 | Film No.: 23790017
SIC: 2834 Pharmaceutical Preparations